This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Au, M. T. et al. Nerve growth factor-targeted molecular theranostics based on molybdenum disulfide nanosheet-coated gold nanorods (MoS2-AuNR) for osteoarthritis pain. ACS Nano https://doi.org/10.1021/acsnano.1c02454 (2021)
Related article
Wise, B. L. et al. The evolution of nerve growth factor inhibition in clinical medicine. Nat. Rev. Rheumatol. 17, 34–46 (2021)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Clarke, J. Going for gold to improve anti-NGF therapy in OA. Nat Rev Rheumatol 17, 508 (2021). https://doi.org/10.1038/s41584-021-00670-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-021-00670-7